
Ashland offers a broad selection of ingredients for effective pharmaceutical excipients, expanding its cellulose-based polymer portfolio (HPMC, HPC, CMC, HEC), growing its excipient offering for injectables and biologics with customization options, and focusing on film coatings. Its pharma portfolio spans oral solid dosage and liquid dosage ingredients, controlled release functionality, coatings, disintegrants, binders and injectables.

No comments available.
Leave your rating & comment